HRH4 and arthritic joint disease: Furthermore, the H4R has been shown to mediate Th17-dependent inflammation in arthritis [101], suggesting that Th17-driven inflammation which has been associated with AD [102–105], particularly in acute skin lesions [106], can also be efficiently countered by H4R antagonists.